Copeland SMID Concentrated Div Growth (S:0P00019SQG)
28.77
-1.96
(-6.38%)
USD |
Mar 31 2026
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of June 04, 2026.
Asset Allocation
| Type | % Net |
|---|
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| The Ensign Group, Inc. | 2.72% | 168.35 | 1.00% |
| LeMaitre Vascular, Inc. | 2.53% | 94.36 | 2.97% |
| The New York Times Co. | 2.51% | 76.80 | 2.18% |
| PriceSmart, Inc. | 2.23% | 173.31 | 1.31% |
| Quest Diagnostics, Inc. | 2.22% | 200.51 | 3.53% |
| Casey's General Stores, Inc. | 2.14% | 768.58 | -0.72% |
| Hexcel Corp. | 2.13% | 89.04 | 1.10% |
| WESCO International, Inc. | 2.03% | 368.12 | -1.71% |
| Valmont Industries, Inc. | 1.99% | 543.31 | -0.70% |
| Littelfuse, Inc. | 1.98% | 475.68 | -1.85% |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
| Minimum Initial Investment | -- |
| Minimum Subsequent Investment | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Last Annual Report Date | -- |
| Last Prospectus Date | -- |
| Attributes | |
| Index Fund | -- |
| Inverse Fund | -- |
| Leveraged Fund | -- |
| Fund of Funds | -- |
| Currency Hedged Fund | -- |
| Synthetic Replication Fund | -- |
| Socially Responsible Fund | -- |